Novavax Inc. (NVAX) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Novavax Inc. (NVAX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

10.17

4.36%

Pre-market Jan 07, 2025, 06:22 AM EST

Novavax Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
License Fees Revenue	9.90M	82.32M	529.16M	2.23M	287.79M	626.09M	55.45M	585.63M
License Fees Revenue Growth	-87.97%	-84.44%	+23618.42%	-99.22%	-54.03%	+1029.01%	-90.53%	n/a
Product Revenue	38.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Product Revenue Growth	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022
Europe Revenue	268.36M	823.54M
Europe Revenue Growth	-67.41%	n/a
North America Revenue	29.96M	194.48M
North America Revenue Growth	-84.60%	n/a
Rest Of The World Revenue	233.07M	536.94M
Rest Of The World Revenue Growth	-56.59%	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	70.75M	101.30M	82.30M	155.24M	107.46M	93.72M	112.53M	161.66M	122.88M	108.16M	95.99M	84.21M	77.79M	73.16M	63.19M	61.31M	56.88M	17.72M	9.38M	8.18M	7.90M	9.61M	8.73M	9.22M	8.31M	8.22M	8.65M	8.54M	8.12M	8.94M	8.85M	8.34M	13.56M	14.10M	10.53M	8.85M	9.06M	7.09M	5.84M
Selling, General, and Administrative Revenue Growth	-30.16%	+23.09%	-46.99%	+44.46%	+14.66%	-16.72%	-30.39%	+31.57%	+13.61%	+12.68%	+13.99%	+8.25%	+6.33%	+15.78%	+3.06%	+7.80%	+221.01%	+88.92%	+14.66%	+3.56%	-17.77%	+10.01%	-5.33%	+11.01%	+1.03%	-4.95%	+1.31%	+5.20%	-9.19%	+0.99%	+6.09%	-38.45%	-3.85%	+33.92%	+18.93%	-2.30%	+27.82%	+21.31%	n/a
Research and Development Revenue	87.16M	106.95M	92.68M	164.70M	106.23M	219.47M	247.10M	257.85M	304.30M	289.65M	383.48M	962.96M	408.19M	570.68M	592.67M	401.20M	294.09M	34.85M	16.89M	29.34M	18.61M	30.42M	35.47M	43.41M	41.33M	44.54M	44.51M	49.66M	41.86M	39.26M	37.65M	51.10M	52.98M	64.90M	68.95M	75.90M	27.92M	25.04M	25.89M
Research and Development Revenue Growth	-18.50%	+15.39%	-43.73%	+55.04%	-51.60%	-11.18%	-4.17%	-15.26%	+5.06%	-24.47%	-60.18%	+135.91%	-28.47%	-3.71%	+47.72%	+36.42%	+743.96%	+106.25%	-42.42%	+57.65%	-38.81%	-14.25%	-18.29%	+5.05%	-7.22%	+0.06%	-10.36%	+18.62%	+6.62%	+4.27%	-26.31%	-3.55%	-18.37%	-5.87%	-9.16%	+171.89%	+11.48%	-3.27%	n/a